A Phase 1/1b Multiple Ascending Dose and Food Effect Study in Healthy Volunteers to Determine the Pharmacokinetics and Maximally Tolerated Dose of Deupirfenidone (LYT-100) Followed by Further Exploration in Patients with Breast Cancer-Related Upper Limb Secondary Lymphoedema

  • Mackie, Helen (Primary Chief Investigator)
  • Koelmeyer, Louise A (Associate Investigator)
  • Chapman, Nicola, (Clinical Trial Unit Staff)
  • Rai, Meenal, (Clinical Trial Unit Staff)

Project: Research

Project Details

AcronymLYT-100-2020-01
StatusActive
Effective start/end date1/08/2025/06/25